Form Bio Co. Ltd. (377220) — Capital Reinvestment Ratio
Latest as of September 2022:
3.43x
Form Bio Co. Ltd. (377220) has a Capital Reinvestment Ratio of 3.43x as of September 2022, meaning it reinvests 3% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩10.55 Billion). See Form Bio Co. Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.43x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.08 Billion
KRW
Capital Expenditures
₩10.55 Billion
KRW
Data as of
Sep 2022
Most recent filing
Form Bio Co. Ltd. Capital Reinvestment Ratio (2019–2020)
This chart tracks Form Bio Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Form Bio Co. Ltd. (2019–2020)
Year-by-year Capital Reinvestment Ratio for Form Bio Co. Ltd. from 2019 to 2020. For live market cap and broader valuation context, see 377220 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.42x | ₩15.61 Billion | ₩6.63 Billion | ▲ +5.6% |
| 2019 | 0.40x | ₩5.68 Billion | ₩2.28 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow